Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography

被引:107
作者
Leen, Edward
Ceccotti, Piercarlo
Kalogeropoulou, Christina
Angerson, Wilson J.
Moug, Susan J.
Horgan, Paul G.
机构
[1] Univ Glasgow, Glasgow Royal Infirm, Dept Radiol, Glasgow G31 2ER, Lanark, Scotland
[2] Glasgow Royal Infirm, Dept Surg, Glasgow G4 0SF, Lanark, Scotland
关键词
contrast-enhanced sonography; liver;
D O I
10.2214/AJR.05.0138
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of this study was to assess the clinical value and potential impact of SonoVue-enhanced sonography in the characterization of focal liver lesions. SUBJECTS AND METHODS. This study included 127 patients with 82 malignant and 52 benign lesions in the liver. Contrast-enhanced sonography was performed using nonlinear imaging modes at low mechanical index (0.1-0.3) to enable real-time visualization of arterial, portal, and late-phase enhancement. Digital recordings of unenhanced sonography and contrast-enhanced sonography were reviewed by on-site investigators and two off-site blinded interpreters. The final diagnosis was based on consensus interpreting of all examinations by another two expert observers with access to CT, MRI, and histologic data; the diagnostic accuracy of contrast-enhanced sonography in identifying the lesion as benign, malignant, or indeterminate and as actual tumor type was compared with baseline sonography. RESULTS. For on-site investigators, contrast-enhanced sonography reduced the number of indeterminate diagnoses by 67% and improved the sensitivity and specificity to 90.2% and 80.8%, respectively (p < 0.001). For off-site interpreters, contrast-enhanced sonography reduced the number of indeterminate diagnoses by 51-56% (p < 0.001); significantly improved sensitivity and specificity to 90.8-95.4% and 83.7-89.8%, respectively (p < 0.001); eliminated observers' variability (kappa coefficient: 0.66-0.77); and showed no significant difference in all comparisons in the analysis of lesions measuring less than 1.5 cm, 1.5-2.5 cm, and all sizes combined. Contrast-enhanced sonography did not rely on availability of clinical history to enable the diagnoses, and it reduced the need for further imaging investigations 23.7% to 90.4%. CONCLUSION. Contrast-enhanced sonography improves the characterization of focal liver lesions and may limit the need for further investigations.
引用
收藏
页码:1551 / 1559
页数:9
相关论文
共 18 条
[1]   Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: Multicenter study [J].
Albrecht, T ;
Blomley, MJK ;
Burns, PN ;
Wilson, S ;
Harvey, CJ ;
Leen, E ;
Claudon, M ;
Calliada, F ;
Correas, JM ;
LaFortune, M ;
Campani, R ;
Hoffmann, CW ;
Cosgrove, DO ;
LeFevre, F .
RADIOLOGY, 2003, 227 (02) :361-370
[2]   Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: Prospective multicenter study [J].
Bryant, TH ;
Blomley, MJ ;
Albrecht, T ;
Sidhu, PS ;
Leen, ELS ;
Basilico, R ;
Pilcher, JM ;
Bushby, LH ;
Hoffmann, CW ;
Harvey, CJ ;
Lynch, M ;
MacQuarrie, J ;
Paul, D ;
Cosgrove, DO .
RADIOLOGY, 2004, 232 (03) :799-809
[3]   Hepatocellular carcinoma - Contrast enhancement with Levovist [J].
Choi, BI ;
Kim, AY ;
Lee, JY ;
Kim, KW ;
Lee, KH ;
Kim, TK ;
Han, JK .
JOURNAL OF ULTRASOUND IN MEDICINE, 2002, 21 (01) :77-84
[4]   Focal hepatic masses: Enhancement patterns with SHU 508A and pulse-inversion US [J].
Dill-Macky, MJ ;
Burns, PN ;
Khalili, K ;
Wilson, SR .
RADIOLOGY, 2002, 222 (01) :95-102
[5]   THE FREQUENCY AND SIGNIFICANCE OF SMALL (GREATER-THAN-OR-EQUAL-TO-15 MM) HEPATIC-LESIONS DETECTED BY CT [J].
JONES, EC ;
CHEZMAR, JL ;
NELSON, RC ;
BERNARDINO, ME .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1992, 158 (03) :535-539
[6]   Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium:: An intravital microscopy study in rats [J].
Kono, Y ;
Steinbach, GC ;
Peterson, T ;
Schmid-Schönbein, GW ;
Mattrey, RF .
RADIOLOGY, 2002, 224 (01) :253-257
[7]   Multi-centre clinical study evaluating the efficacy of SonoVue™ (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions [J].
Leen, E ;
Angerson, WJ ;
Yarmenitis, S ;
Bongartz, G ;
Blomley, M ;
Del Maschio, A ;
Summaria, V ;
Maresca, G ;
Pezzoli, C ;
Llull, JB .
EUROPEAN JOURNAL OF RADIOLOGY, 2002, 41 (03) :200-206
[8]   The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions [J].
Leen, E .
EUROPEAN RADIOLOGY, 2001, 11 (Suppl 3) :E27-E34
[9]   Characterization of focal liver lesions in real time using harmonic imaging with high mechanical index and contrast agent levovist [J].
Migaleddu, V ;
Virgilio, G ;
Turilli, D ;
Conti, M ;
Campisi, G ;
Canu, N ;
Sirigu, D ;
Vincentelli, I .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 182 (06) :1505-1512
[10]   Focal liver lesions: Evaluation of the efficacy of gadobenate dimeglumine in MR imaging - A multicenter phase III clinical study [J].
Petersein, J ;
Spinazzi, A ;
Giovagnoni, A ;
Soyer, P ;
Terrier, F ;
Lencioni, R ;
Bartolozzi, C ;
Grazioli, L ;
Chiesa, A ;
Manfredi, R ;
Marano, P ;
van Meerten, ELV ;
Bloem, JL ;
Petre, C ;
Marchal, G ;
Greco, A ;
McNamara, MT ;
Heuck, A ;
Reiser, M ;
Laniado, M ;
Claussen, C ;
Daldrup, HE ;
Rummeny, E ;
Kirchin, MA ;
Pirovano, G ;
Hamm, B .
RADIOLOGY, 2000, 215 (03) :727-736